Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Cash from Financing Activities (2023 - 2025)

Upstream Bio (UPB) has 3 years of Cash from Financing Activities data on record, last reported at $760000.0 in Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 146.31% year-over-year to $760000.0; the TTM value through Sep 2025 reached $272.0 million, up 83.61%, while the annual FY2024 figure was $418.9 million, 223.36% up from the prior year.
  • Cash from Financing Activities reached $760000.0 in Q3 2025 per UPB's latest filing, up from $612000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $270.6 million in Q4 2024 and bottomed at -$1.6 million in Q3 2024.
  • Average Cash from Financing Activities over 3 years is $52.5 million, with a median of $686000.0 recorded in 2025.
  • Peak YoY movement for Cash from Financing Activities: soared 203594.74% in 2024, then crashed 100.36% in 2025.
  • A 3-year view of Cash from Financing Activities shows it stood at -$133000.0 in 2023, then skyrocketed by 203594.74% to $270.6 million in 2024, then crashed by 99.72% to $760000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $760000.0 in Q3 2025, $612000.0 in Q2 2025, and -$34000.0 in Q1 2025.